Stefan Reuberger

Title: The Innovations of Stefan Reuberger

Introduction

Stefan Reuberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of adeno-associated virus (AAV) purification methods. With a total of two patents to his name, Reuberger's work has the potential to impact various applications in gene therapy and virology.

Latest Patents

Reuberger's latest patents focus on innovative methods for producing and purifying adeno-associated viruses. These patents detail techniques for purifying AAV products and full AAV capsids from concentrated AAV fractions that include both empty and full capsids. His work in this area is crucial for advancing the efficiency and effectiveness of AAV-based therapies.

Career Highlights

Stefan Reuberger is currently associated with Takeda Pharmaceutical Company Limited, where he continues to develop his expertise in biotechnology. His role at Takeda allows him to collaborate with other professionals in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Reuberger has worked alongside esteemed colleagues such as Christian Fiedler and Meinhard Hasslacher. These collaborations have fostered an environment of innovation and have led to the advancement of important biotechnological methods.

Conclusion

Stefan Reuberger's contributions to the field of biotechnology, particularly in adeno-associated virus purification methods, highlight his role as a significant inventor. His work not only enhances our understanding of AAV but also paves the way for future advancements in gene therapy.